A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

Saved in:

Bibliographic Details
Title:	A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
Authors:	Gómez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Neciosup S; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Tosello C; Instituto Brasileiro de Controle do Câncer, São Paulo, São Paulo, Brazil., Mano M; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Bines J; Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil., Santi PX; Instituto de Ensino e Pesquisa São Lucas, Santo André, Brazil., Pinczowski H; Instituto de Ensino e Pesquisa São Lucas, Santo André, Brazil., Nerón Y; Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis, Brazil., Fanelli M; Hospital A.C. Camargo, São Paulo, Brazil., Fein L; Centro Oncológico de Rosário, Rosário, Argentina., Sampaio C; Clínica Amo, Salvador, Brazil., Lerzo G; Investigaciones Clínicas Ciudad de Buenos Aires, Buenos Aires, Argentina., Capó A; Fundación Centro Oncológico de Integración Regional, Mendoza, Argentina., Zarba JJ; Centro San Roque, Tucumán, Argentina., Blajman C; ISIS Clínica Especializada, Santa Fé, Argentina., Varela MS; CER Instituto Médico, Buenos Aires, Argentina., Martínez-Mesa J; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: gustavo.werutsky@lacog.org.br., Barrios CH; Pontifical Catholic University of Rio Grande do Sul School of Medicine, Hospital São Lucas, Porto Alegre, Brazil.
Source:	Clinical breast cancer [Clin Breast Cancer] 2016 Feb; Vol. 16 (1), pp. 38-44. Date of Electronic Publication: 2015 Nov 10.
Publication Type:	Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1938-0666
DOI:	10.1016/j.clbc.2015.10.005